Overview of Safety of Fluticasone Furoate, Vilanterol, or Their Combination in COPD Patients With Moderate Airflow Obstruction: The Summit Trial

Authors
Category Primary study
JournalCHEST
Year 2016
This article has no abstract
Epistemonikos ID: b208048f1164931f627ca4052c19385dc3c7bc1c
First added on: Feb 08, 2025